IMRIS Inc. announced that Vipul Patel has joined the SYMBIS(TM) Surgical System Advisory Board. Dr. Patel is currently the medical director of the Global Robotics Institute and the urologic oncology program for the Florida Hospital Cancer Institute.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2022 | IMRIS Inc. (OTCPK:IMRS.Q) acquired Superconducting Systems Inc. | CI |
2022 | IMRIS Inc. announced that it has received funding from Trinity Capital Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 62 | |
+10.13% | 67.32B | |
+3.33% | 16.79B | |
+10.24% | 13.55B | |
+21.47% | 13.59B | |
+12.01% | 9.9B | |
-23.32% | 6.56B | |
-5.04% | 5.93B | |
+0.24% | 5.11B | |
-3.01% | 4.86B |
- Stock Market
- Equities
- IMRS.Q Stock
- News IMRIS Inc.
- IMRIS Inc. Appoints Vipul Patel to Symbis Advisory Board